Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Targacept, Glaxo end alliance
Bizjournals.com
Thursday, March 3, 2011 - 11:34am
tags:
GSK, Targacept
BioSante Pharmaceuticals pancreatic cancer drug meets study goals, shares jump
Yahoo/AP
Thursday, March 3, 2011 - 11:33am
tags:
BioSante, pancreatic cancer
J&J’s Risperdal Consta No Better Than Cheaper Drugs in Study
Bloomberg
Thursday, March 3, 2011 - 11:20am
tags:
JNJ, Risperdal Consta, schizophrenia, antipsychotics
Who Wins What in the High Court’s $100M Drug Sales Rep Ruling
BNET Pharma
Thursday, March 3, 2011 - 9:16am
tags:
drug reps, overtime lawsuits
Avanir Primed for a Rebound?
Seeking Alpha
Thursday, March 3, 2011 - 9:13am
tags:
Avanir, Nuedexta, PBA
Why We Need Comparative Effectiveness Research
Forbes
Thursday, March 3, 2011 - 9:09am
tags:
comparative effectiveness, Merck, JNJ, Abbott Laboratories
Amgen Execs Take The 5th Over Alleged Kickbacks
Pharmalot
Thursday, March 3, 2011 - 8:52am
tags:
Amgen, kickbacks, Aranesp, anemia
FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone
Yahoo
Thursday, March 3, 2011 - 8:50am
tags:
FDA, Cell Therapeutics, pixantrone
Pending FDA Approval Means Mannkind Is Down, But It's Not Out
Seeking Alpha
Thursday, March 3, 2011 - 8:49am
tags:
FDA, inhaled insulin, MannKind, Afrezza
Chelsea Therapeutics has wider 4Q loss on R&D cost
Yahoo/AP
Thursday, March 3, 2011 - 8:48am
tags:
Chelsea Therapeutics, earnings
J&J Recall Watch: Ethicon Recalls 104 Batches of Sutures
WSJ Online
Thursday, March 3, 2011 - 8:47am
tags:
Ethicon, JNJ, recalls
Eisai Forecasts Flat Sales Through 2016 After Patent Loss
Bloomberg
Thursday, March 3, 2011 - 7:58am
tags:
Eisai, earnings, guidance
When Will Dendreon Make Money?
Motley Fool
Thursday, March 3, 2011 - 7:57am
tags:
Dendreon, vaccines, prostate cancer, Provenge
Sanofi plans autonomy for part of Genzyme business
Yahoo/AP
Thursday, March 3, 2011 - 7:24am
tags:
M&A, Genzyme, Sanofi, orphan drugs
Narrower Q4 Loss at Isis
Yahoo/Zacks.com
Thursday, March 3, 2011 - 7:23am
tags:
earnings, Isis Pharmaceuticals
Dividend Report Card: Johnson & Johnson
Motley Fool
Thursday, March 3, 2011 - 7:22am
tags:
JNJ, dividends
Vertex’s Telaprevir Reduces Hepatitis Rates in HIV Patients
Bloomberg
Thursday, March 3, 2011 - 7:21am
tags:
Vertex Pharmaceuticals, HIV, hepatitis C, Telaprevir
Avastin gets to keep its breast cancer use in Europe
Fierce Pharma
Wednesday, March 2, 2011 - 12:01pm
tags:
Avastin, breast cancer, Europe, Roche
Biotech Calendar: Key Dates for March
TheStreet.com
Wednesday, March 2, 2011 - 11:59am
tags:
Human Genome Sciences, Dendreon, Cell Therapeutics, AP Pharma, Bristol-Myers Squibb, Celgene, Corcept Therapeutics, Achillion
Clinical Data Sued Over Forest Laboratories Takeover Plan
Bloomberg
Wednesday, March 2, 2011 - 11:57am
tags:
Clinical Data, Forest Labs, M&A, shareholders

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.